Pathogenetic and Prognostic Significance of Thrombocytopenia in Patients With Necrotizing Soft Tissue Infections

Necrotizing soft tissue infection (NSTI) is a severe surgical infection which can result in sepsis and septic shock when generalized.

The aim of the study was to determine the frequency of thrombocytopenia in patients with generalized NSTI, the factors promoting its development, and its association with septic shock.

Materials and Methods. We examined 129 patients with NSTI treated between 09.2015 and 12.2019 at St. George Hospital in St. Petersburg, Russia. Surgical treatment, hematological and biochemical examinations, and bacteriological analysis of blood and wound discharge were performed in each patient. The studied group included 22 patients with systemic inflammatory reaction syndrome, 63 patients with sepsis, and 44 patients with septic shock.

Results. We found a decrease in platelet count in NSTI patients with septic shock as early as on the first day of the disease and its further decrease within the next 3 days, with the mean platelet volume (MPV) increasing during the same period and significantly exceeding that in patients with sepsis and systemic inflammatory response syndrome. In NSTI patients with thrombocytopenia on admission, we found a significant correlation between the platelet count and the percentage of segmented neutrophils (r=0.349; P<0.001; n=40). The maximum incidenсe of septic shock was observed in patients infected with Klebsiella pneumoniae (13 out of 19, 65%). These patients had the highest MPV but did not develop thrombocytopenia. Maximum frequency of thrombocytopenia and elevation of MPV and platelet distribution width (PDW) was found in patients with NSTI and underlying chronic viral hepatitis C. However, the relative frequency of septic shock in these patients was not increased.

Conclusion. The development of septic shock in NSTI is associated with a specific platelet activation pattern

1. Surgical infections of the skin and soft tissues. Russian national recommendations. Ed. B.R. Gelfand. Ed. 2nd revised and add. M., 2015: 109. ISBN 978-5-4316-0235-1. [In Russ.].

2. Pallin D.J., Egan D.J., Pelletier A.J., Espinola J.A., Hooper D.C., Camargo C.A. Jr. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med. 2008; 51 (3): 291-298. DOI: 10.1016/j.annemergmed.2007.12.004

3. Tessier JM, Sanders J, Sartelli M, Sartelli M., Ulrych J., De Simone B., Grabowski J., Buckman S. Duane T.M. Operative Management, Antimicrobial Therapy, and Pediatrics. Surg Infect (Larchmt). 2020; 21 (2): 81–93. DOI: 10.1089/sur.2019.219

4. Beloborodov V.B Complicated infections of the skin and soft tissues: modern features of antibacterial therapy. Consilium Medicum. 2017.19 (72. surgery) 7: 2 DOI: 10.26442/2075-1753_19.7.2.7-12) [In Russ.].

5. Barkhatova N.A. of surgical treatment of local and generalized forms of purulent-necrotic soft tissue infection. Genius of Orthopedics. 2010: 4. URL: https://cyberleninka.ru/article/n/osobennosti-hirurgicheskogo-lecheniya-lokalnoy-i-generalizovannyh-form-gnoynonekroticheskoy-infektsii-myagkih-tkaney. [In Russ.].

6. Grinev M.V., Grinev K.M. Necrotizing fasciitis. SPb.: Hippokrat, 2008.120 р. ISBN. 978-5-8232-02 51-0. [In Russ.].

7. Singer M., Deutschman C.S., Seymour C.W.; Shankar-Hari M., Annane D., Bauer M., Bellomo R., Bernard G.R., Chiche J.-D., Coopersmith C.M., Hotchkiss R.S., Levy M., Marshall J.C., Martin G.S., Opal S.M., Rubenfeld G.D., van der Poll T., Vincent J.-L., Angus D. C. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA., 2016; 315 (8): 801-810. DOI: 10.1001/jama.2016.0287

8. Thiery-Antier N., Binquet C., Vinault S., Meziani F., Boisramé-Helms J., Quenot J.-P., EPIdemiology of Septic Shock Group. Is Thrombocytopenia an Early Prognostic Marker in Septic Shock?. Crit Care Med., 2016; 44 (4): 764–772. DOI: 10.1097/CCM.0000000000001520

9. Koyama K,. Katayama S., Muronoi T., Tonai K,. Yuya G., Toshitaka K., Shima J., Shin N. Time course of immature platelet count and its relation to thrombocytopenia and mortality in patients with sepsis. PloS one, 2018; 13 (1): e0192064. DOI: 10.1371/journal.pone.0192064

10. Serebryanaya N.B., Yakutseni P.P. Platelets in the development of sepsis, septic shock and multiple organ failure syndrome. Medical Immunology. 2020; 22 (6): 1085–1096 [In Russ.]. DOI: 10.15789/1563-0625-BPI-2090

11. Serebryanaya N.B., Shanin S.N., Fomicheva E.E., Yakutseni P.P. Platelets as activators and regulators of inflammatory and immune responses. Part 1. The main characteristics of platelets as inflammatory cells. Medical immunology. 2018; 20 (6): 785–796 DOI: 10.15789/1563-0625-2018-6-785-796 [In Russ.].

12. Deppermann C., Kubes P. Platelets and infection. Semin Immunol. 2016; 28 (6): 536–545. DOI: 10.1016/j.smim.2016.10.005

13. Cox D., Kerrigan S.W., Watson S.P. Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation. J Thromb Haemost. 2011; 9 (6): 1097–1107. DOI: 10.1111/j.1538-7836.2011.04264.x

14. Serebryanaya N.B., Yakutseni P.P., Klimko N.N. The role of platelets in the pathogenesis of bacterial infections. Jurnal Infektologiii. 2017; 9 (4): 5–13 DOI: 10.22625/2072-6732-2017-9-4-5-13 [In Russ.].

15. Greco E., Lupia E., Bosco O., Vizio B., Montrucchio G. Platelets and Multi-Organ Failure in Sepsis. Int J Mol Sci. 2017; 18 (10): 2200. DOI: 10.3390/ijms18102200

16. Shlyapnikov S.A., Shchegolev A.V. (ed.). Clinical guidelines for the diagnosis and treatment of severe sepsis and septic shock in treatment and prevention organizations of St. Petersburg. SPB: publishing house of OOO BMN; 2017: 76s. [In Russ.]

17. Bone R. C., Balk R. A., Cerra F. B. Dellinger R. P., Fein M., Knaus W. A., Schein R. M., Sibbald W. J. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992; 101 (6): 1644–1655. DOI: 10.1378/chest.101.6.1644.

18. Sharma B., Sharma M., Majumder M,. Steier W., Sangal A., Kalawar M. Thrombocytopenia in septic shock patients — a prospective observational study of incidence, risk factors and correlation with clinical outcome. Anaesth Intensive Care. 2007; 35 (6): 874–880. DOI: 10.1177/0310057X0703500604

19. Jol S., Hietbrink F., Leenen L.P., Koenderman L., van Wessem K.J. Similar change in platelets and leucocytes 24 h after injury is associated with septic shock a week later. ANZ J Surg. 2017; 87 (3): 190–194. DOI: 10.1111/ans.13861

20. Venkata C., Kashyap R., Farmer J.C., Afessa B. Thrombocytopenia in adult patients with sepsis: incidence, risk factors, and its association with clinical outcome. J Intensive Care. 2013; 1 (1): 9. DOI: 10.1186/2052-0492-1-9

21. Tóth J., Debreceni I.B., Berhés M., Hajdú E., Deák Á., Pető K., Szabó J., Németh N., Fülesdi B., Kappelmayer J. Red blood cell and platelet parameters are sepsis predictors in an Escherichia coli induced lethal porcine model. Clin Hemorheol Microcirc. 2017; 66 (3): 249–259. DOI: 10.3233/CH-170271

22. Aydemir H., Piskin N., Akduman D., Kokturk F., Aktas E. Platelet and mean platelet volume kinetics in adult patients with sepsis. Platelets. 2015; 26 (4): 331-335. DOI: 10.3109/09537104.2012.701027

23. Farias M.G., Schunck E.G., Dal Bó S., de Castro S.M. Definition of reference ranges for the platelet distribution width (PDW): a local need. Clin Chem Lab Med. 2010; 48 (2): 255–257. DOI: 10.1515/CCLM.2010.035

24. Yilmaz Z., Eralp O., Ilcol Y.O. Evaluation of platelet count and its association with plateletcrit, mean platelet volume, and platelet size distribution width in a canine model of endotoxemia. Veterinary Clinical Pathology. 200; 37 (2): 159–163. DOI: 10.1111/j.1939-165x.2008.00023.x.

25. de Stoppelaar S.F., van ‘t Veer C., van der Poll T. The role of platelets in sepsis. Thromb Haemost. 2014; 112 (4): 666–677. DOI: 10.1160/TH14-02-0126

26. Xiang B., Zhang G., Guo L., Li X.-A., Morris A.J., Daugherty A., Whiteheart S.W., Smyth S.S., Li Z. Platelets protect from septic shock by inhibiting macrophage-dependent inflammation via the cyclooxygenase 1 signalling pathway. Nat Commun. 2013; 4: 2657. DOI: 10.1038/ncomms3657

27. Cloutier N., Allaeys I., Marcoux G., Machlus K.R., Mailhot B., Zufferey A., Levesque T., Becker Y., Tessandier N., Melki I., Zhi H., Poirier G., Rondina M.T., Italiano J.E., Flamand L., McKenzie S.E., Cote F., Nieswandt B., Khan W.I., Flick M.J., Newman P.J., Lacroix S., Fortin P.R., Boilard E. Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration. Proc Natl Acad Sci U S A. 2018; 115 (7): E1550–E1559. DOI: 10.1073/pnas.1720553115

28. Dabiré H. Central 5-hydroxytryptamine (5-HT) receptors in blood pressure regulation. Therapie. 1991; 46 (6): 421–429. PMID: 1819150

29. Duerschmied D., Suidan G.L., Demers M., Herr N., Carbo C., Brill A., Cifuni S.M., Mauler M., Cicko S., Bader M., Idzko M., Bode C., Wagner D.D. Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice. Blood. 2013; 121 (6): 1008–1015. DOI: 10.1182/blood-2012-06-437392

30. Hoffmeister K.M., Falet H. Platelet clearance by the hepatic AshwellMorrell receptor: mechanisms and biological significance. Thromb Res. 2016; 141 (Suppl 2): S68–S72. DOI: 10.1016/S0049-3848(16)30370-X

31. Qian J, Liu G, Wang R, Liu J, Liu Y, Liang S, Lu W. [Risk factors for sepsis in patients with hepatic failure]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019; 31 (7): 900–902. [in Chinese]. DOI: 10.3760/cma.j.issn.2095-4352.2019.07.020. PMID: 31441418de

32. de Almeida A.J., Campos-de-Magalhães M., de Melo Marçal O.P., Brandão-Mello C.E., Okawa M.Y., de Oliveira R.V., do Espírito-Santo M.P., Yoshida C.F., Lampe E. Hepatitis C virus-associated thrombocytopenia: a controlled prospective, virological study. Ann Hematol. 2004; 83 (7): 434–440. DOI: 10.1007/s00277-004-0844-0. PMID: 14963696.

33. de Almeida A.J., Campos-de-Magalhães M., Brandão-Mello C.E., de Oliveira R.V., Yoshida C.F., Lampe E. Detection of hepatitis C virus in platelets: evaluating its relationship to viral and host factors. Hepatogastroenterology. 2007; 54 (75): 964–968. PMID: 17591104